VEGFA and neovascular glaucoma: The therapy regime in our case to prevent radiation retinopathy and neovascular glaucoma is the use of anti-VEGF every 2 months (Regeneron Pharmaceuticals, Inc., Tarrytown, USA; intravitreal ziv-aflibercept 1.25 mg/0.05 ml) alternating with corticosteroids intravitreal every 2 months (Sooft s.p.a., Fermo, Italy; Vitreal S 0.1 ml).